Skip to main content
Serum Uromodulin: A Biomarker of Long-Term Kidney Allograft Failure.
American journal of nephrology
  • Andrew Bostom
  • Dominik Steubl
  • Pranav S Garimella
  • Nora Franceschini
  • Mary B Roberts
  • Andreas Pasch
  • Joachim H Ix
  • Katherine Tuttle, Providence Health Care, Spokane, WA
  • Anastasia Ivanova
  • Theresa Shireman
  • S Joseph Kim
  • Reginald Gohh
  • Daniel E Weiner
  • Andrew S Levey
  • Chi-Yuan Hsu
  • John W Kusek
  • Charles B Eaton
Document Type
Publication Date
  • Kidney allograft failure,
  • Kidney transplantation,
  • Serum uromodulin

BACKGROUND: Uromodulin is a kidney-derived glycoprotein and putative tubular function index. Lower serum uromodulin was recently associated with increased risk for kidney allograft failure in a preliminary, longitudinal single-center -European study involving 91 kidney transplant recipients (KTRs).

METHODS: The Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) trial is a completed, large, multiethnic controlled clinical trial cohort, which studied chronic, stable KTRs. We conducted a case cohort analysis using a randomly selected subset of patients (random subcohort, n = 433), and all individuals who developed kidney allograft failure (cases, n = 226) during follow-up. Serum uromodulin was determined in this total of n = 613 FAVORIT trial participants at randomization. Death-censored kidney allograft failure was the study outcome.

RESULTS: The 226 kidney allograft failures occurred during a median surveillance of 3.2 years. Unadjusted, weighted Cox proportional hazards modeling revealed that lower serum uromodulin, tertile 1 vs. tertile 3, was associated with a threefold greater risk for kidney allograft failure (hazards ratio [HR], 95% CI 3.20 [2.05-5.01]). This association was attenuated but persisted at twofold greater risk for allograft failure, after adjustment for age, sex, smoking, allograft type and vintage, prevalent diabetes mellitus and cardiovascular disease (CVD), total/high-density lipoprotein cholesterol ratio, systolic blood pressure, estimated glomerular filtration rate, and natural log urinary albumin/creatinine: HR 2.00, 95% CI (1.06-3.77).

CONCLUSIONS: Lower serum uromodulin, a possible indicator of less well-preserved renal tubular function, remained associated with greater risk for kidney allograft failure, after adjustment for major, established clinical kidney allograft failure and CVD risk factors, in a large, multiethnic cohort of long-term, stable KTRs.

Clinical Institute
Kidney & Diabetes
Citation Information
Andrew Bostom, Dominik Steubl, Pranav S Garimella, Nora Franceschini, et al.. "Serum Uromodulin: A Biomarker of Long-Term Kidney Allograft Failure." American journal of nephrology (2018)
Available at: